 | • レポートコード：20QY06-04458 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、医薬品用中間体のグローバル市場について種類別（GMP、非GMP）、用途別（抗生物質、解熱鎮痛剤、ビタミン、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・医薬品用中間体市場の概要 ・世界の主要地域別医薬品用中間体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の医薬品用中間体市場規模2015-2026：種類別（GMP、非GMP） ・世界の医薬品用中間体市場規模2015-2026：用途別（抗生物質、解熱鎮痛剤、ビタミン、その他） ・医薬品用中間体の北米市場規模2015-2020 ・医薬品用中間体のヨーロッパ市場規模2015-2020 ・医薬品用中間体の中国市場規模2015-2020 ・医薬品用中間体の日本市場規模2015-2020 ・医薬品用中間体の東南アジア市場規模2015-2020 ・医薬品用中間体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Lonza、Catalent、Patheon、Jubilant、Granules、Ganesh、Chemcon、BASF、Porton、Lianhetech、ABA Chem、Tianma、Jiujiujiu、Alpha、Jiuzhou、Yongtai） ・医薬品用中間体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・医薬品用中間体の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Pharmaceutical Intermediates Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Pharmaceutical Intermediates market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmaceutical Intermediates market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pharmaceutical Intermediates industry.
Based on our recent survey, we have several different scenarios about the Pharmaceutical Intermediates YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 160290 million in 2019. The market size of Pharmaceutical Intermediates will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Pharmaceutical Intermediates market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Pharmaceutical Intermediates market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Pharmaceutical Intermediates market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Pharmaceutical Intermediates market. The report also includes nautical information, where it shows Pharmaceutical Intermediates market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Pharmaceutical Intermediates market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Pharmaceutical Intermediates market.
This industry is affected by the economy and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to rising environment standards, especially in underdevelopment regions that have a large population and fast economic growth, the need will increase.
Geographical Analysis:
Based on region, the global Pharmaceutical Intermediates market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Pharmaceutical Intermediates market are
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Segment by Type
GMP
Non-GMP
Segment by Application
Antibiotics
Antipyretic Analgesics
Vitamins
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Pharmaceutical Intermediates market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Pharmaceutical Intermediates market.
• The market share of the global Pharmaceutical Intermediates market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Pharmaceutical Intermediates market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Pharmaceutical Intermediates market.
1 Pharmaceutical Intermediates Market Overview
1.1 Pharmaceutical Intermediates Product Scope
1.2 Pharmaceutical Intermediates Segment by Type
1.2.1 Global Pharmaceutical Intermediates Sales by Type (2020-2026)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Pharmaceutical Intermediates Segment by Application
1.3.1 Global Pharmaceutical Intermediates Sales Comparison by Application (2020-2026)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Pharmaceutical Intermediates Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pharmaceutical Intermediates Sales Growth Rate (2015-2026)
1.4.2 Global Pharmaceutical Intermediates Revenue and Growth Rate (2015-2026)
1.4.3 Global Pharmaceutical Intermediates Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Intermediates Industry Impact
1.5.1 How the Covid-19 is Affecting the Pharmaceutical Intermediates Industry
1.5.1.1 Pharmaceutical Intermediates Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pharmaceutical Intermediates Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
2 Pharmaceutical Intermediates Estimate and Forecast by Region
2.1 Global Pharmaceutical Intermediates Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pharmaceutical Intermediates Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
2.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Region (2015-2020)
2.3 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pharmaceutical Intermediates Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pharmaceutical Intermediates Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pharmaceutical Intermediates Estimates and Projections (2015-2026)
2.4.2 Europe Pharmaceutical Intermediates Estimates and Projections (2015-2026)
2.4.3 China Pharmaceutical Intermediates Estimates and Projections (2015-2026)
2.4.4 Japan Pharmaceutical Intermediates Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pharmaceutical Intermediates Estimates and Projections (2015-2026)
2.4.6 India Pharmaceutical Intermediates Estimates and Projections (2015-2026)
3 Global Pharmaceutical Intermediates Competition Landscape by Players
3.1 Global Top Pharmaceutical Intermediates Players by Sales (2015-2020)
3.2 Global Top Pharmaceutical Intermediates Players by Revenue (2015-2020)
3.3 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2019)
3.4 Global Pharmaceutical Intermediates Average Price by Company (2015-2020)
3.5 Manufacturers Pharmaceutical Intermediates Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pharmaceutical Intermediates Players (Opinion Leaders)
4 Global Pharmaceutical Intermediates Market Size by Type
4.1 Global Pharmaceutical Intermediates Historic Market Review by Type (2015-2020)
4.1.1 Global Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
4.1.2 Global Pharmaceutical Intermediates Revenue Market Share by Type (2015-2020)
4.1.3 Global Pharmaceutical Intermediates Price by Type (2014-2020)
4.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2021-2026)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2021-2026)
4.2.3 Global Pharmaceutical Intermediates Price Forecast by Type (2021-2026)
5 Global Pharmaceutical Intermediates Market Size by Application
5.1 Global Pharmaceutical Intermediates Historic Market Review by Application (2015-2020)
5.1.1 Global Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
5.1.2 Global Pharmaceutical Intermediates Revenue Market Share by Application (2015-2020)
5.1.3 Global Pharmaceutical Intermediates Price by Application (2015-2020)
5.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pharmaceutical Intermediates Sales Forecast by Application (2021-2026)
5.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2021-2026)
5.2.3 Global Pharmaceutical Intermediates Price Forecast by Application (2021-2026)
3 North America Pharmaceutical Intermediates Market Facts & Figures
3.2 North America Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
3.3 North America Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
3.4 North America Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
4 Europe Pharmaceutical Intermediates Market Facts & Figures
4.2 Europe Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
4.3 Europe Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
4.4 Europe Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
5 China Pharmaceutical Intermediates Market Facts & Figures
5.2 China Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
5.3 China Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
5.4 China Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
6 Japan Pharmaceutical Intermediates Market Facts & Figures
6.2 Japan Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
6.3 Japan Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
6.4 Japan Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
7 Southeast Asia Pharmaceutical Intermediates Market Facts & Figures
7.2 Southeast Asia Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
8 India Pharmaceutical Intermediates Market Facts & Figures
8.2 India Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
8.3 India Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
8.4 India Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pharmaceutical Intermediates Business
12.1 Lonza
12.1.1 Lonza Pharmaceutical Intermediates Corporation Information
12.1.2 Lonza Pharmaceutical Intermediates Business Overview and Total Revenue
12.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Lonza Pharmaceutical Intermediates Products Offered
12.1.5 Lonza Recent Development
12.2 Catalent
12.2.1 Catalent Pharmaceutical Intermediates Corporation Information
12.2.2 Catalent Pharmaceutical Intermediates Business Overview and Total Revenue
12.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Catalent Pharmaceutical Intermediates Products Offered
12.2.5 Catalent Recent Development
12.3 Patheon
12.3.1 Patheon Pharmaceutical Intermediates Corporation Information
12.3.2 Patheon Pharmaceutical Intermediates Business Overview and Total Revenue
12.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Patheon Pharmaceutical Intermediates Products Offered
12.3.5 Patheon Recent Development
12.4 Jubilant
12.4.1 Jubilant Pharmaceutical Intermediates Corporation Information
12.4.2 Jubilant Pharmaceutical Intermediates Business Overview and Total Revenue
12.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Jubilant Pharmaceutical Intermediates Products Offered
12.4.5 Jubilant Recent Development
12.5 Granules
12.5.1 Granules Pharmaceutical Intermediates Corporation Information
12.5.2 Granules Pharmaceutical Intermediates Business Overview and Total Revenue
12.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Granules Pharmaceutical Intermediates Products Offered
12.5.5 Granules Recent Development
12.6 Ganesh
12.6.1 Ganesh Pharmaceutical Intermediates Corporation Information
12.6.2 Ganesh Pharmaceutical Intermediates Business Overview and Total Revenue
12.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ganesh Pharmaceutical Intermediates Products Offered
12.6.5 Ganesh Recent Development
12.7 Chemcon
12.7.1 Chemcon Pharmaceutical Intermediates Corporation Information
12.7.2 Chemcon Pharmaceutical Intermediates Business Overview and Total Revenue
12.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Chemcon Pharmaceutical Intermediates Products Offered
12.7.5 Chemcon Recent Development
12.8 BASF
12.8.1 BASF Pharmaceutical Intermediates Corporation Information
12.8.2 BASF Pharmaceutical Intermediates Business Overview and Total Revenue
12.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.8.4 BASF Pharmaceutical Intermediates Products Offered
12.8.5 BASF Recent Development
12.9 Porton
12.9.1 Porton Pharmaceutical Intermediates Corporation Information
12.9.2 Porton Pharmaceutical Intermediates Business Overview and Total Revenue
12.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Porton Pharmaceutical Intermediates Products Offered
12.9.5 Porton Recent Development
12.10 Lianhetech
12.10.1 Lianhetech Pharmaceutical Intermediates Corporation Information
12.10.2 Lianhetech Pharmaceutical Intermediates Business Overview and Total Revenue
12.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
12.10.5 Lianhetech Recent Development
12.11 ABA Chem
12.11.1 ABA Chem Pharmaceutical Intermediates Corporation Information
12.11.2 ABA Chem Pharmaceutical Intermediates Business Overview and Total Revenue
12.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.11.4 ABA Chem Pharmaceutical Intermediates Products Offered
12.11.5 ABA Chem Recent Development
12.12 Tianma
12.12.1 Tianma Pharmaceutical Intermediates Corporation Information
12.12.2 Tianma Pharmaceutical Intermediates Business Overview and Total Revenue
12.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Tianma Pharmaceutical Intermediates Products Offered
12.12.5 Tianma Recent Development
12.13 Jiujiujiu
12.13.1 Jiujiujiu Pharmaceutical Intermediates Corporation Information
12.13.2 Jiujiujiu Pharmaceutical Intermediates Business Overview and Total Revenue
12.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Jiujiujiu Pharmaceutical Intermediates Products Offered
12.13.5 Jiujiujiu Recent Development
12.14 Alpha
12.14.1 Alpha Pharmaceutical Intermediates Corporation Information
12.14.2 Alpha Pharmaceutical Intermediates Business Overview and Total Revenue
12.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Alpha Pharmaceutical Intermediates Products Offered
12.14.5 Alpha Recent Development
12.15 Jiuzhou
12.15.1 Jiuzhou Pharmaceutical Intermediates Corporation Information
12.15.2 Jiuzhou Pharmaceutical Intermediates Business Overview and Total Revenue
12.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Jiuzhou Pharmaceutical Intermediates Products Offered
12.15.5 Jiuzhou Recent Development
12.16 Yongtai
12.16.1 Yongtai Pharmaceutical Intermediates Corporation Information
12.16.2 Yongtai Pharmaceutical Intermediates Business Overview and Total Revenue
12.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Yongtai Pharmaceutical Intermediates Products Offered
12.16.5 Yongtai Recent Development
13 Pharmaceutical Intermediates Manufacturing Cost Analysis
13.1 Pharmaceutical Intermediates Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pharmaceutical Intermediates
13.4 Pharmaceutical Intermediates Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pharmaceutical Intermediates Distributors List
14.3 Pharmaceutical Intermediates Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pharmaceutical Intermediates Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Pharmaceutical Intermediates Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pharmaceutical Intermediates Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pharmaceutical Intermediates Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
Table 8. Global Market Pharmaceutical Intermediates Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pharmaceutical Intermediates Sales (K MT) by Region (2015-2020)
Table 10. Global Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
Table 11. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pharmaceutical Intermediates Revenue Share by Region (2015-2020)
Table 13. Global Pharmaceutical Intermediates Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pharmaceutical Intermediates Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pharmaceutical Intermediates Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pharmaceutical Intermediates (K MT) of Key Companies (2015-2020)
Table 18. Global Pharmaceutical Intermediates Sales Share by Company (2015-2020)
Table 19. Global Pharmaceutical Intermediates Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pharmaceutical Intermediates Revenue Share by Company (2015-2020)
Table 21. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2019)
Table 22. Global Pharmaceutical Intermediates Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Pharmaceutical Intermediates Manufacturing Sites and Area Served
Table 24. Manufacturers Pharmaceutical Intermediates Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pharmaceutical Intermediates Players
Table 27. Global Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 28. Global Pharmaceutical Intermediates Sales Share by Type (2015-2020)
Table 29. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pharmaceutical Intermediates Price (K MT) by Type (2015-2020)
Table 31. Global Pharmaceutical Intermediates Sales Share by Type (2021-2026)
Table 32. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pharmaceutical Intermediates Revenue Share by Type (2021-2026)
Table 34. Global Pharmaceutical Intermediates Price (K MT) by Type (2021-2026)
Table 35. Global Pharmaceutical Intermediates Sales (K MT) by Application (2015-2020)
Table 36. Global Pharmaceutical Intermediates Sales Share by Application (2015-2020)
Table 37. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pharmaceutical Intermediates Price (K MT) by Application (2015-2020)
Table 39. Global Pharmaceutical Intermediates Sales (K MT) by Application (2021-2026)
Table 40. Global Pharmaceutical Intermediates Sales Share by Application (2021-2026)
Table 41. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pharmaceutical Intermediates Revenue Share by Application (2021-2026)
Table 43. Global Pharmaceutical Intermediates Price (K MT) by Application (2021-2026)
Table 44. United States Pharmaceutical Intermediates Sales (K MT) by Company (2015-2020)
Table 45. United States Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
Table 46. United States Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 47. United States Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 48. United States Pharmaceutical Intermediates Sales (K MT) by Application (2015-2020)
Table 49. United States Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 50. Europe Pharmaceutical Intermediates Sales (K MT) by Company (2015-2020)
Table 51. Europe Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
Table 52. Europe Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 53. Europe Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 54. Europe Pharmaceutical Intermediates Sales (K MT) by Application (2015-2020)
Table 55. Europe Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 56. China Pharmaceutical Intermediates Sales (K MT) by Company (2015-2020)
Table 57. China Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
Table 58. China Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 59. China Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 60. China Pharmaceutical Intermediates Sales (K MT) by Application (2015-2020)
Table 61. China Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 62. Japan Pharmaceutical Intermediates Sales (K MT) by Company (2015-2020)
Table 63. Japan Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
Table 64. Japan Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 65. Japan Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 66. Japan Pharmaceutical Intermediates Sales (K MT) by Application (2015-2020)
Table 67. Japan Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pharmaceutical Intermediates Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 74. India Pharmaceutical Intermediates Sales (K MT) by Company (2015-2020)
Table 75. India Pharmaceutical Intermediates Sales Market Share by Company (2015-2020)
Table 76. India Pharmaceutical Intermediates Sales (K MT) by Type (2015-2020)
Table 77. India Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 78. India Pharmaceutical Intermediates Sales (K MT) by Application (2015-2020)
Table 79. India Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 80. Lonza Corporation Information
Table 81. Lonza Description and Business Overview
Table 82. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Lonza Pharmaceutical Intermediates Product
Table 84. Lonza Recent Development
Table 85. Catalent Corporation Information
Table 86. Catalent Description and Business Overview
Table 87. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Catalent Pharmaceutical Intermediates Product
Table 89. Catalent Recent Development
Table 90. Patheon Corporation Information
Table 91. Patheon Description and Business Overview
Table 92. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Patheon Pharmaceutical Intermediates Product
Table 94. Patheon Recent Development
Table 95. Jubilant Corporation Information
Table 96. Jubilant Description and Business Overview
Table 97. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Jubilant Pharmaceutical Intermediates Product
Table 99. Jubilant Recent Development
Table 100. Granules Corporation Information
Table 101. Granules Description and Business Overview
Table 102. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Granules Pharmaceutical Intermediates Product
Table 104. Granules Recent Development
Table 105. Ganesh Corporation Information
Table 106. Ganesh Description and Business Overview
Table 107. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Ganesh Pharmaceutical Intermediates Product
Table 109. Ganesh Recent Development
Table 110. Chemcon Corporation Information
Table 111. Chemcon Description and Business Overview
Table 112. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Chemcon Pharmaceutical Intermediates Product
Table 114. Chemcon Recent Development
Table 115. BASF Corporation Information
Table 116. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. BASF Description and Business Overview
Table 118. BASF Pharmaceutical Intermediates Product
Table 119. BASF Recent Development
Table 120. Porton Corporation Information
Table 121. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Porton Description and Business Overview
Table 123. Porton Pharmaceutical Intermediates Product
Table 124. Porton Recent Development
Table 125. Lianhetech Corporation Information
Table 126. Lianhetech Description and Business Overview
Table 127. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Lianhetech Pharmaceutical Intermediates Product
Table 129. Lianhetech Recent Development
Table 130. ABA Chem Corporation Information
Table 131. ABA Chem Description and Business Overview
Table 132. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. ABA Chem Pharmaceutical Intermediates Product
Table 134. ABA Chem Recent Development
Table 135. Tianma Corporation Information
Table 136. Tianma Description and Business Overview
Table 137. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Tianma Pharmaceutical Intermediates Product
Table 139. Tianma Recent Development
Table 140. Jiujiujiu Corporation Information
Table 141. Jiujiujiu Description and Business Overview
Table 142. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Jiujiujiu Pharmaceutical Intermediates Product
Table 144. Jiujiujiu Recent Development
Table 145. Alpha Corporation Information
Table 146. Alpha Description and Business Overview
Table 147. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Alpha Pharmaceutical Intermediates Product
Table 149. Alpha Recent Development
Table 150. Jiuzhou Corporation Information
Table 151. Jiuzhou Description and Business Overview
Table 152. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Jiuzhou Pharmaceutical Intermediates Product
Table 154. Jiuzhou Recent Development
Table . Yongtai Corporation Information
Table . Yongtai Description and Business Overview
Table . Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Yongtai Pharmaceutical Intermediates Product
Table . Yongtai Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Pharmaceutical Intermediates Distributors List
Table 163. Pharmaceutical Intermediates Customers List
Table 164. Market Key Trends
Table 165. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 166. Key Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pharmaceutical Intermediates Market Share by Application in 2020 & 2026
Figure 6. Antibiotics Examples
Figure 7. Antipyretic Analgesics Examples
Figure 8. Vitamins Examples
Figure 9. Others Examples
Figure 10. Global Pharmaceutical Intermediates Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Pharmaceutical Intermediates Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Pharmaceutical Intermediates Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Pharmaceutical Intermediates Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Pharmaceutical Intermediates Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Pharmaceutical Intermediates Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Pharmaceutical Intermediates Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Pharmaceutical Intermediates Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Pharmaceutical Intermediates Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Pharmaceutical Intermediates Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Pharmaceutical Intermediates Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Pharmaceutical Intermediates Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Pharmaceutical Intermediates Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pharmaceutical Intermediates Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Pharmaceutical Intermediates Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Pharmaceutical Intermediates Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Pharmaceutical Intermediates Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Pharmaceutical Intermediates Players Market Share by Revenue in Pharmaceutical Intermediates 2015 & 2019
Figure 28. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Pharmaceutical Intermediates Revenue Share by Type (2015-2020)
Figure 30. Global Pharmaceutical Intermediates Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Pharmaceutical Intermediates Revenue Share by Application (2015-2020)
Figure 32. Global Pharmaceutical Intermediates Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 34. United States Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 35. Europe Pharmaceutical Intermediates Sales Market Share by Company in 2019
Figure 36. Europe Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 37. Europe Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 38. China Pharmaceutical Intermediates Sales Market Share by Company in 2019
Figure 39. China Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 40. China Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 41. Japan Pharmaceutical Intermediates Sales Market Share by Company in 2019
Figure 42. Japan Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 43. Japan Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 44. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Company in 2019
Figure 45. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 46. Southeast Asia Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 47. India Pharmaceutical Intermediates Sales Market Share by Company in 2019
Figure 48. India Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 49. India Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 50. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Jubilant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Granules Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ganesh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Chemcon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. BASF Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Porton Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Lianhetech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. ABA Chem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Tianma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Jiujiujiu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Alpha Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Jiuzhou Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Yongtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Pharmaceutical Intermediates
Figure 68. Manufacturing Process Analysis of Pharmaceutical Intermediates
Figure 69. Pharmaceutical Intermediates Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
化学中間体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chemical Intermediates market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chemical Intermediates…- 製薬用化学品の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Pharmaceutical Chemicals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 234040 million by 2025, from USD 194980 million in 2019. The Pharmaceuti…
- ヒアルロン酸の世界市場レポート2020 Market Analysis and Insights: Global H Acid Market The global H Acid market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H Acid Scope and Market Size The global H Acid market is segmented by Type, and by Appl…
- 製薬ファインケミカルの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Pharmaceutical Fine Chemicals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.4% in the forecast period of 2020 to 2025 and will expected to reach USD 136500 million by 2025, from USD 106380 million in 2019. The Pharma…
- 3-アミノピリジンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global 3-Aminopyridine (CAS CAS 462-08-8) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The 3-Aminopyr…